Status:
RECRUITING
Altshock-2 REGISTRY
Lead Sponsor:
Niguarda Hospital
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
The study will provide data on profile, management, outcome, and evolution over time of cardiogenic shock patients admitted to the Intensive Coronary Care Units
Detailed Description
Cardiogenic shock (CS) is the most severe form of acute heart failure. Data on epidemiology of CS have been drawn from previously published registries focussing on acute coronary syndrome (ACS) and my...
Eligibility Criteria
Inclusion
- All consecutive CS patients hospitalized in the above reported centres between January 2020 and December 2030.
- Cardiogenic shock is defined as:
- Systolic blood pressure (SBP) \<90 mmHg or mean arterial pressure (MAP) \<60 mmHg, after an appropriate fluid challenge if there is no sign of overt fluid overload, OR need of vasoactive agents to maintain SBP \> 90 mmHg or MAP \> 60 mmHg, OR need of MCS;
- At least one of the following criteria/signs of overt hypoperfusion: mixed venous oxygen saturation \<60%; arterial lactates \> 2 mmol/L; oliguria \< 0.5 ml/Kg/h for at least 6 hours.
Exclusion
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2031
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04295252
Start Date
July 1 2020
End Date
December 31 2031
Last Update
March 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST GOM Niguarda
Milan, Italy, 20125